Aethlon Medical, Inc. (Nasdaq:AEMD), is an immunotherapeutic technology company focused on unmet needs in global health.  Today they announced that its CEO, Jim Joyce, will present at the 2018 BIO Investor Forum on Thursday, October 18, 2018 at 3:15 p.m. Pacific Time.  The event is being held at the Westin St. Francis Hotel in San Francisco, California.  A live audio webcast of the presentation can be accessed at http://www.aethlonmedical.com/news-media/presentations.  A replay of the webcast will be available until January 15, 2019.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here